Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Post-cesarean Pain in Buprenorphine Patients
NCT03335436Phase 4Withdrawn
- Sponsor
- Vanderbilt University Medical Center
- Start
- Apr 2018
- Primary completion
- Nov 2020
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of gabapentin in pain, sponsored by Vanderbilt University Medical Center. Planned start Apr 2018; status: withdrawn.
02
Drugs
gabapentin
03
Conditions
pain
Beyond the preview
Go deeper on NCT03335436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03335436.